C
5.98
-0.26 (-4.17%)
| Previous Close | 6.24 |
| Open | 6.30 |
| Volume | 192,175 |
| Avg. Volume (3M) | 186,575 |
| Market Cap | 125,128,248 |
| Price / Sales | 27.16 |
| Price / Book | 4.99 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Operating Margin (TTM) | -2,976.89% |
| Diluted EPS (TTM) | -1.07 |
| Quarterly Revenue Growth (YOY) | 103.30% |
| Current Ratio (MRQ) | 8.84 |
| Operating Cash Flow (TTM) | -15.26 M |
| Levered Free Cash Flow (TTM) | -10.29 M |
| Return on Assets (TTM) | -32.06% |
| Return on Equity (TTM) | -52.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Coya Therapeutics, Inc. | Bearish | Mixed |
AIStockmoo Score
1.4
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 1.38 |
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 7.02% |
| % Held by Institutions | 28.08% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 16.00 (BTIG, 167.56%) | Buy |
| Median | 15.00 (150.84%) | |
| Low | 14.00 (Chardan Capital, 134.11%) | Buy |
| Average | 15.00 (150.84%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 5.95 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| D. Boral Capital | 09 Dec 2025 | 15.00 (150.84%) | Buy | 6.02 |
| 12 Nov 2025 | 15.00 (150.84%) | Buy | 6.09 | |
| Chardan Capital | 14 Nov 2025 | 14.00 (134.11%) | Buy | 5.87 |
| 17 Sep 2025 | 14.00 (134.11%) | Buy | 5.41 | |
| BTIG | 13 Nov 2025 | 16.00 (167.56%) | Buy | 5.96 |
| 30 Sep 2025 | 15.00 (150.84%) | Buy | 5.70 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |